Clinical implementation of artificial intelligence assistance in pathology workflow

niversity Medical Center Utrecht0 sites260 target enrollmentMay 31, 2023

Overview

No summary available.

Registry

who.int

Start Date

May 31, 2023

End Date

December 31, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•Health professionals:
•1\.1\. PCa: dedicated uropathologists
•1\.2\. BCa: dedicated breast pathologists
•1\.1\. PCa: adult males of any age undergoing prostate needle biopsies at the investigation site will be enrolled in the study and have their diagnosis determined in a prospective, consecutive manner.
•1\.2\. BCa: adult females or males of any age with breast cancer as primary malignancy whose SN\-specimen is assessed at the investigation site will be enrolled in the study and have their diagnosis determined in a prospective, consecutive manner.
•2\. All specimens that are H\&E\-stained and glass or film cover\-slipped will be evaluated. Adjacent unstained slides will available for IHC staining.
•3\. The WSIs fulfill the quality checks described in the scanner manufacturer’s Instruction for Use and general clinical practice.
•4\. No diagnostic markings and patient identifiable markings are visible on the slides.

•1\. Patients who were referred for a second opinion
•2\. Patients that have opted out of all medical research
•3\. Cases in which the associated IHC\-stained slides are unavailable/cannot be generated
•4\. Cases not meeting defined quality criteria for digital clinical primary diagnosis evaluation